J&J vaccine effective against COVID Delta variant, drugmaker says
By
Alicia Lasek
Jul 06, 2021
Johnson & Johnson’s single-shot COVID-19 vaccine prompts a “strong neutralizing antibody response” that lasts at least eight months, the drugmaker has announced.
COVID ‘breakthrough’ outbreak affects one quarter of residents at French nursing home
By
Alicia Lasek
Sep 15, 2021
In a facility with a 97% resident vaccination rate, the large number of infections shows that a shot alone is not enough to protect the frail elderly from SARS-CoV-2, researchers contend.
Stay on guard: Vaccinated residents remain susceptible to outbreaks, French nursing home studies reveal
By
Alicia Lasek
Jul 13, 2021
Vaccinations and infection control measures may not entirely protect nursing homes from COVID-19 outbreaks — especially when staff members are unvaccinated, according to two new studies from France.
Manageable risks for dementia and heart disease are closely linked, AHA’s annual report finds
By
Alicia Lasek
Jan 27, 2022
There is growing evidence that what is good for the heart is good for the brain. But that knowledge and awareness has not yet trickled down to patients, the authors say.
Lack of access to coronavirus tests still a top concern for nursing homes
By
Danielle Brown
Apr 09, 2020
Providers are still having trouble securing reliable coronavirus testing despite healthcare facility workers being named a priority under federal guidance.
Lessons from an orphan
By
Gary Tetz
Jun 30, 2016
It’s a disquieting visual I can’t quite get out of my mind — a single hiking boot hanging from a trail sign. Even you, a crisis-tested long-term care professional, might feel surprised and...
CDC advises COVID boosters for all adults, citing worrisome omicron variant
By
Alicia Lasek
Nov 30, 2021
The new recommendation comes amid rising concerns about the omicron coronavirus variant — yet another reason to get an additional vaccine dose, health officials say.
Feds identify promising and ‘urgently needed’ COVID antiviral drug
By
Alicia Lasek
Jun 04, 2021
The experimental drug TEMPOL has shown promise in early studies, halting the activity of a viral enzyme and limiting the severity of SARS-CoV-2 infections.
Clinical briefs for Thursday, June 3
By
Alicia Lasek
Jun 03, 2021
Nursing homes’ smaller but continued COVID outbreaks blamed on unvaccinated staff, report finds … U.S. to test mixed COVID vaccine booster dose schedules in vaccinated adults … WHO plans to simplify...
COVID cases rise in 15 states; variant fuels outbreak in Kentucky nursing home
By
Alicia Lasek
Mar 22, 2021
The average U.S. case rate is falling, but almost a third of states have seen an increase, and one Kentucky facility’s outbreak shows how new COVID-19 variants and vaccination play a role in continued...